1. Out remaining $CELG long, 92.32 ave

  2. Bouncing Range $SPX Market Update and Scan for Oct 20 http://blog.afraidtotrade.com/bouncing-range-market-update-and-scan-for-oct-20/ $HPQ $IBM $ISRG $CELG $TRIP $$

  3. $CELG Not sure why this didn t gap up in the early AM when positive data was released but it was a great last chance to buy. :)

  4. $CELG. Good news here. http://news.investors.com/102014-722520-celg-stock-rises-as-mongersen-succeeds-in-trial.htm?ven=yahoocp&src=aurlled&ven=yahoo

  5. $CELG testing ma-50 like GILD. Both will go over..need patient

  6. $CELG Blair sees data as risk-debulking event. Keeps op

  7. Nice move in $CELG lately. Stock remains cheap. #101 overall. I remain long.

  8. $CELG This data should be a nice wake up call to the Street that Celgene will be able to provide sustainable growth for years to come.

  9. Last 4 qrtrs of $CELG s price movement on the earnings announcement. Reporting on Thursday. http://www.tradingthedate.com/stocks/CELG?utm_campaign=Earnings+X+Days&utm_medium=social&utm_source=stocktwits

  10. @breakingeven Right, just pointing it out. Somebody was complaining $CELG was only up half of $GILD on friday. I m long both

  11. @long_sovaldi $CELG is half the size of $GILD . Easier to make bigger moves with less money

  12. $CELG up 2x more than $GILD today...

  13. $CELG A potential breakout play above $96.50. The technical indicator shows a strong buy. http://www.stoxline.com/quote.php?symbol=CELG

  14. $CELG cant believe I paid $85 for this 4 sessions ago. Hopefully it pulls back a bit & I can add.

  15. $CELG http://www.shortanalytics.com/getshortchart.php?tsymbol=celg A lot of shorts may have been caught hoping for bad data for the Crohn s drug...

  16. $CELG http://www.fiercebiotech.com/story/celgenes-26b-deal-crohns-drug-pays-promising-phii/2014-10-20?utm_medium=rss&utm_source=rss&utm_campaign=rss Celgene s $2.6B deal for Crohn s drug pays off with promising PhII

  17. $CELG http://seekingalpha.com/article/2574345-end-of-the-year-events-to-drive-some-of-octobers-beaten-up-biotech-companies?page=2 End Of The Year Events To Drive Some Of October s Beaten Up Biotech Companies

  18. $CELG GED-0301 treatment resulted in significant improvements in clinical remission & response rates within 4 weeks of initiating treatment.

  19. $CELG http://uegw.congress-online.com/guest/AbstractView?ABSID=8730 Here is the GED-0301 (mongersen) Crohn’s abstract...

  20. $CELG https://twitter.com/adamfeuerstein/status/524150270511415297 Analysts heaping love on GED-0301...ph2 Crohn’s abstract. Clinical profile looks better than biologics. -- AF

  21. $CELG Phase II Data in Crohn s Disease for Celgene s Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014 http://www.finances.com/company-news/25767-phase-ii-data-in-crohns-disease-for-celgenes-oral-antisense-therapy-ged-0301-to-be-presented-at-ueg-week-2014.htm

  22. $CELG Phase II Data in Crohn’s Disease for Celgene’s Oral Antisense Therapy GED-0301 to Be Presented a.. http://boardvote.com/symbol/CELG/communique/792917

  23. $CELG https://twitter.com/adamfeuerstein/status/524151359390502912/photo/1 Mongersen Abstract

  24. $CELG Screaming buy ahead of earnings + possible positive crohn s data.

  25. $GILD $CELG Better load up on $CALA. There s massive insider buying going on.